Search research articles
Contact Us
Filters
Showing results (121-130 of 204) with videos related to
Page
of 21
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications
|
July 20, 2000
High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxide
D J Swaine, P M Loadman, M C Bibby, et al.
Molecular Medicine Reports
|
April 8, 2011
Potentiation of the activity of cisplatin in a human colon tumour xenograft model by auristatin PYE, a structural modification of dolastatin 10
Ekatherine M Prokopiou, Patricia A Cooper, George R Pettit, et al.
International Journal of Oncology
|
December 5, 2003
The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment
D Alwyn Dart, Steven M Picksley, Patricia A Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1
P M Loadman, M C Bibby, J A Double, et al.
International Journal of Oncology
|
July 6, 2007
Auristatin PYE, a novel synthetic derivative of dolastatin 10, is highly effective in human colon tumour models
Steven D Shnyder, Patricia A Cooper, Nicola J Millington, et al.
British Journal of Cancer
|
March 1, 1992
In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity
R M Phillips, P B Hulbert, M C Bibby, et al.
British Journal of Cancer
|
April 3, 1999
Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice
M C Bibby, M J Thompson, J A Rafferty, et al.
Archiv Der Pharmazie
|
November 1, 1996
Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 1: 6-Methyl derivatives
R A Aitken, M C Bibby, J A Double, et al.
Anti-Cancer Drug Design
|
March 1, 1996
Pharmacokinetics and anti-tumour activity of B.4152, a reactive molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, and its uracil analogue
P M Loadman, A M Matthew, J E McCormick, et al.
Pharmaceutical Research
|
August 16, 2002
A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres
Anne Aubert-Pouëssel, David C Bibby, Marie-claire Venier-Julienne, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 204) with videos related to
Sort By:
Page
of 21
Journal of Chromatography. B, Biomedical Sciences and Applications
|
July 20, 2000
High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxide
D J Swaine, P M Loadman, M C Bibby, et al.
Molecular Medicine Reports
|
April 8, 2011
Potentiation of the activity of cisplatin in a human colon tumour xenograft model by auristatin PYE, a structural modification of dolastatin 10
Ekatherine M Prokopiou, Patricia A Cooper, George R Pettit, et al.
International Journal of Oncology
|
December 5, 2003
The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment
D Alwyn Dart, Steven M Picksley, Patricia A Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1
P M Loadman, M C Bibby, J A Double, et al.
International Journal of Oncology
|
July 6, 2007
Auristatin PYE, a novel synthetic derivative of dolastatin 10, is highly effective in human colon tumour models
Steven D Shnyder, Patricia A Cooper, Nicola J Millington, et al.
British Journal of Cancer
|
March 1, 1992
In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity
R M Phillips, P B Hulbert, M C Bibby, et al.
British Journal of Cancer
|
April 3, 1999
Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice
M C Bibby, M J Thompson, J A Rafferty, et al.
Archiv Der Pharmazie
|
November 1, 1996
Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 1: 6-Methyl derivatives
R A Aitken, M C Bibby, J A Double, et al.
Anti-Cancer Drug Design
|
March 1, 1996
Pharmacokinetics and anti-tumour activity of B.4152, a reactive molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, and its uracil analogue
P M Loadman, A M Matthew, J E McCormick, et al.
Pharmaceutical Research
|
August 16, 2002
A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres
Anne Aubert-Pouëssel, David C Bibby, Marie-claire Venier-Julienne, et al.
Page
of 21